  <rdf:RDF
    xmlns:vitro="http://vitro.mannlib.cornell.edu/ns/vitro/0.7#"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
    xmlns:cito="http://purl.org/spar/cito/"
    xmlns:scires="http://vivoweb.org/ontology/scientific-research#"
    xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#"
    xmlns:j.0="https://repository.healthpartners.com.com/field/"
    xmlns:hpi="/knowledgeexchange/ontology/"
    xmlns:ocresd="http://purl.org/net/OCRe/study_design.owl#"
    xmlns:ocrer="http://purl.org/net/OCRe/research.owl#"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:obo="http://purl.obolibrary.org/obo/"
    xmlns:owl="http://www.w3.org/2002/07/owl#"
    xmlns:geo="http://aims.fao.org/aos/geopolitical.owl#"
    xmlns:c4o="http://purl.org/spar/c4o/"
    xmlns:event="http://purl.org/NET/c4dm/event.owl#"
    xmlns:j.1="http://repository.healthpartners.com/ontology/dspace/"
    xmlns:vcard="http://www.w3.org/2006/vcard/ns#"
    xmlns:skos="http://www.w3.org/2004/02/skos/core#"
    xmlns:bibo="http://purl.org/ontology/bibo/"
    xmlns:fabio="http://purl.org/spar/fabio/"
    xmlns:vivo="http://vivoweb.org/ontology/core#"
    xmlns:foaf="http://xmlns.com/foaf/0.1/"
    xmlns:xsd="http://www.w3.org/2001/XMLSchema#"
    xmlns:vitro-public="http://vitro.mannlib.cornell.edu/ns/vitro/public#">
  <owl:Class rdf:about="http://purl.org/ontology/bibo/Article">
    <rdfs:label xml:lang="en-US">Article</rdfs:label>
  </owl:Class>
  <owl:Class rdf:about="http://www.w3.org/2002/07/owl#Thing"/>
  <owl:Class rdf:about="http://purl.org/ontology/bibo/Document">
    <rdfs:label xml:lang="en-US">Document</rdfs:label>
  </owl:Class>
  <owl:Class rdf:about="http://purl.org/ontology/bibo/AcademicArticle">
    <rdfs:label xml:lang="en-US">Academic Article</rdfs:label>
  </owl:Class>
  <owl:Class rdf:about="http://purl.obolibrary.org/obo/IAO_0000030">
    <rdfs:label xml:lang="en-US">Information Content Entity</rdfs:label>
  </owl:Class>
  <owl:Class rdf:about="http://purl.obolibrary.org/obo/BFO_0000002">
    <rdfs:label>Continuant</rdfs:label>
    <rdfs:label xml:lang="en-US">Continuant</rdfs:label>
  </owl:Class>
  <owl:Class rdf:about="http://purl.obolibrary.org/obo/IAO_0000013">
    <rdfs:label xml:lang="en-US">Journal Article</rdfs:label>
  </owl:Class>
  <owl:Class rdf:about="http://purl.obolibrary.org/obo/BFO_0000001">
    <rdfs:label>Entity</rdfs:label>
    <rdfs:label xml:lang="en-US">Entity</rdfs:label>
  </owl:Class>
  <owl:Class rdf:about="http://purl.obolibrary.org/obo/BFO_0000031">
    <rdfs:label xml:lang="en-US">Generically Dependent Continuant</rdfs:label>
  </owl:Class>
  <foaf:Document rdf:about="/knowledgeexchange/individual/document-rn18734/document-rn18734.rdf">
    <dc:rights rdf:resource="http://repository.healthpartners.com/termsOfUse"/>
    <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime"
    >2025-05-09T09:59:46</dc:date>
    <dc:publisher rdf:resource="http://repository.healthpartners.com"/>
    <rdfs:label>RDF description of Hormone-refractory prostate cancer: a shifting paradigm in treatment - http://repository.healthpartners.com/individual/document-rn18734</rdfs:label>
  </foaf:Document>
  <obo:IAO_0000013 rdf:about="http://repository.healthpartners.com/individual/document-rn18734">
    <vivo:freetextKeyword>Risk Factors</vivo:freetextKeyword>
    <j.1:itemId>20062</j.1:itemId>
    <bibo:abstract>&lt;p&gt;Prostate cancer, the most common male cancer, affects one in eight American men. Risk factors for the disease include increased age, race, and family history of prostate cancer. To date, surgery, radiation, and hormonal therapy have been the mainstays of treatment. In the past, chemotherapy served only a palliative role for men with prostate cancer and failed to produce a survival advantage or any significant measurable disease response. However, for the first time, docetaxel-based regimens have demonstrated improved survival in men with hormone-refractory prostate cancer in two different, large, phase III studies. Additionally, a number of novel agents are being developed with the hope that treatment for men with hormone-refractory prostate cancer will be improved. Oncology nurses provide critical symptom management strategies as well as education to men with prostate cancer and their partners. Therefore, maintaining current state of the knowledge about best practices and treatment for prostate cancer is crucial. This, in turn, directs efforts to educate patients and family members about treatments and management of side effects.&lt;p&gt;</bibo:abstract>
    <vivo:freetextKeyword>Taxoids/adverse effects/therapeutic use</vivo:freetextKeyword>
    <vitro:mostSpecificType rdf:resource="http://purl.obolibrary.org/obo/IAO_0000013"/>
    <vivo:relatedBy>
      <vivo:Authorship rdf:about="http://repository.healthpartners.com/individual/document-rn18734-authorship-author2">
        <rdf:type rdf:resource="http://vivoweb.org/ontology/core#Relationship"/>
        <rdf:type rdf:resource="http://purl.obolibrary.org/obo/BFO_0000020"/>
        <rdf:type rdf:resource="http://purl.obolibrary.org/obo/BFO_0000001"/>
        <rdf:type rdf:resource="http://purl.obolibrary.org/obo/BFO_0000002"/>
        <rdf:type rdf:resource="http://www.w3.org/2002/07/owl#Thing"/>
        <vivo:relates rdf:resource="http://repository.healthpartners.com/individual/document-rn18734"/>
      </vivo:Authorship>
    </vivo:relatedBy>
    <vivo:freetextKeyword>Prognosis</vivo:freetextKeyword>
    <rdf:type rdf:resource="http://purl.org/ontology/bibo/Document"/>
    <vivo:identifier>document-rn18734</vivo:identifier>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/BFO_0000002"/>
    <j.0:updatedDateTime rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime"
    >2022-02-21T22:48:57.408-06:00</j.0:updatedDateTime>
    <bibo:volume>10</bibo:volume>
    <vivo:freetextKeyword>Drugs, Investigational</vivo:freetextKeyword>
    <vivo:freetextKeyword>Prostatic Neoplasms/*drug therapy/epidemiology/nursing/pathology</vivo:freetextKeyword>
    <vivo:dateTimeValue>
      <obo:BFO_0000148 rdf:about="http://repository.healthpartners.com/individual/document-rn18734-dtv">
        <rdf:type rdf:resource="http://purl.obolibrary.org/obo/BFO_0000008"/>
        <rdf:type rdf:resource="http://vivoweb.org/ontology/core#DateTimeValue"/>
        <rdf:type rdf:resource="http://purl.obolibrary.org/obo/BFO_0000003"/>
        <rdf:type rdf:resource="http://purl.obolibrary.org/obo/BFO_0000001"/>
        <rdf:type rdf:resource="http://www.w3.org/2002/07/owl#Thing"/>
      </obo:BFO_0000148>
    </vivo:dateTimeValue>
    <rdf:type rdf:resource="http://purl.org/ontology/bibo/AcademicArticle"/>
    <bibo:doi>10.1188/06.cjon.233-240</bibo:doi>
    <rdf:type rdf:resource="http://purl.org/ontology/bibo/Article"/>
    <vivo:hasPublicationVenue>
      <bibo:Collection rdf:about="http://repository.healthpartners.com/individual/journal-Clinical-Journal-of-Oncology-Nursing">
        <rdf:type rdf:resource="http://purl.obolibrary.org/obo/BFO_0000002"/>
        <rdf:type rdf:resource="http://purl.org/ontology/bibo/Journal"/>
        <rdf:type rdf:resource="http://purl.obolibrary.org/obo/BFO_0000001"/>
        <vivo:publicationVenueFor rdf:resource="http://repository.healthpartners.com/individual/document-rn18734"/>
        <rdf:type rdf:resource="http://www.w3.org/2002/07/owl#Thing"/>
        <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000030"/>
        <rdf:type rdf:resource="http://purl.obolibrary.org/obo/BFO_0000031"/>
        <rdf:type rdf:resource="http://purl.org/ontology/bibo/Periodical"/>
        <rdfs:label>Clinical Journal of Oncology Nursing</rdfs:label>
      </bibo:Collection>
    </vivo:hasPublicationVenue>
    <vivo:relatedBy>
      <vivo:Authorship rdf:about="http://repository.healthpartners.com/individual/document-rn18734-authorship-author1">
        <rdf:type rdf:resource="http://vivoweb.org/ontology/core#Relationship"/>
        <rdf:type rdf:resource="http://purl.obolibrary.org/obo/BFO_0000020"/>
        <rdf:type rdf:resource="http://purl.obolibrary.org/obo/BFO_0000001"/>
        <rdf:type rdf:resource="http://purl.obolibrary.org/obo/BFO_0000002"/>
        <rdf:type rdf:resource="http://www.w3.org/2002/07/owl#Thing"/>
        <vivo:relates rdf:resource="http://repository.healthpartners.com/individual/document-rn18734"/>
      </vivo:Authorship>
    </vivo:relatedBy>
    <rdfs:label>Hormone-refractory prostate cancer: a shifting paradigm in treatment</rdfs:label>
    <j.1:handle>12741</j.1:handle>
    <vivo:freetextKeyword>Patient Education as Topic</vivo:freetextKeyword>
    <hpi:flagPublic>public</hpi:flagPublic>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/BFO_0000031"/>
    <vivo:freetextKeyword>Docetaxel</vivo:freetextKeyword>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000030"/>
    <vivo:freetextKeyword>Antineoplastic Agents/adverse effects/*therapeutic use</vivo:freetextKeyword>
    <rdf:type rdf:resource="http://www.w3.org/2002/07/owl#Thing"/>
    <bibo:issue>2</bibo:issue>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/BFO_0000001"/>
    <vivo:freetextKeyword>Androgen Antagonists/adverse effects/*therapeutic use</vivo:freetextKeyword>
  </obo:IAO_0000013>
</rdf:RDF>